Pharmacological management in frontotemporal dementia and patient outcomes: a retrospective cohort study using the TriNetX platform
Symptomatic treatment remains the cornerstone of therapeutic management in frontotemporal dementia (FTD), as disease-modifying therapies are currently unavailable. However, several medications originally developed for other neuropsychiatric conditions may represent potentially harmful medications (PHMs) in FTD. This st...